Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018.

Murray, Ciara; D'Arcy, Clare; Gullo, Giuseppe; Flanagan, Louise; Quinn, Cecily M

Murray, Ciara; D'Arcy, Clare; Gullo, Giuseppe; Flanagan, Louise; Quinn, Cecily M.

Afiliação

Murray C; 1 St Vincent's University Hospital, Dublin, Ireland.
D'Arcy C; 1 St Vincent's University Hospital, Dublin, Ireland.
Gullo G; 1 St Vincent's University Hospital, Dublin, Ireland.
Flanagan L; 1 St Vincent's University Hospital, Dublin, Ireland.
Quinn CM; 1 St Vincent's University Hospital, Dublin, Ireland.

Arch Pathol Lab Med ; 143(4): 412-413, 2019 04.

Article em En | MEDLINE | ID: mdl-30605368

Assuntos

Neoplasias da Mama; Biomarcadores Tumorais; Humanos; Hibridização in Situ Fluorescente; Oncologia; Patologistas; Receptor ErbB-2/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google